The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
miR-183 in Prostate Cancer Cells Positively Regulates Synthesis and Serum Levels of Prostate-specific Antigen
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“They could be utilized as general cancer biomarkers [5,33,41,42,43,44,45].”
From Bioinformatic Interrogation of 5p-arm and 3p-arm Specific miRNA Expression Using TCGA Datasets (2015) · cites this paper as [41]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Screening and Prostate-Cancer Mortality in a Randomized European Study
Schröder, F. H., Hugosson, J., Roobol, M. J., Tammela, T. L. J., Ciatto, S., Nelen, V., KWIATKOWSKI, M. K., Lujan, M., Lilja, H. G., Zappa, M., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0810084 · Cited by 4,016
Self-citationIntegrative Genomic Profiling of Human Prostate Cancer
Taylor, B. S., Schultz, N. D., Hieronymus, H., Gopalan, A., Xiao, Y., Carver, B. S., Arora, V. K., Kaushik, P., Cerami, E. G., Reva, B. A., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.05.026 · Cited by 3,743
Switching from Repression to Activation: MicroRNAs Can Up-Regulate Translation
Vasudevan, S., Tong, Y., & STEITZ, J. A. (2007) · Science · doi:10.1126/science.1149460 · Cited by 2,911
miR-145 and miR-143 regulate smooth muscle cell fate and plasticity
Cordes, K. R., Sheehy, N. T., White, M. P., Berry, E. C., Morton, S. U., Muth, A. N., Lee, T.-H., Miano, J. M., Ivey, K. N., & Srivastava, D. (2009) · Nature · doi:10.1038/nature08195 · Cited by 1,585
MicroRNA-10a binds the 5’UTR of ribosomal protein mRNAs and enhances their translation
Ørom, U. A., Nielsen, F. C., & Lund, A. H. (2008) · Molecular Cell · doi:10.1016/j.molcel.2008.05.001 · Cited by 1,384
RankProd: a bioconductor package for detecting differentially expressed genes in meta-analysis
Hong, F., Breitling, R., McEntee, C. W., Wittner, B. S., Nemhauser, J. L., & Chory, J. (2006) · Bioinformatics · doi:10.1093/bioinformatics/btl476 · Cited by 752
Christensson, A. G., Laurell, C., & Lilja, H. G. (1990) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1990.tb19466.x · Cited by 640
Self-citationDiagnostic and prognostic implications of microRNA profiling in prostate carcinoma
Schaefer, A., Jung, M., Mollenkopf, H., Wagner, I., Stephan, C., Jentzmik, F., Miller, K., Lein, M., Kristiansen, G., & Jung, K. (2010) · International Journal of Cancer · doi:10.1002/ijc.24827 · Cited by 611
MicroRNA Sequence and Expression Analysis in Breast Tumors by Deep Sequencing
Farazi, T. A., Horlings, H. M., ten Hoeve, J. J., Mihailovic, A., Halfwerk, H., Morozov, P., Brown, M., Hafner, M., Reyal, F., van Kouwenhove, M., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-0608 · Cited by 346
Myatt, S. S., Wang, J., Monteiro, L. J., Christian, M., Ho, K.-K., Fusi, L., Dina, R. E., Brosens, J. J., Ghaem-Maghami, S., & Lam, E. W.-F. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-1891 · Cited by 318
Systematic Analysis of MicroRNAs Targeting the Androgen Receptor in Prostate Cancer Cells
Östling, P., Leivonen, S.-K., Aakula, A., Kohonen, P., Mäkelä, R., Hagman, Z., Edsjö, A., Kangaspeska, S., Edgren, H., Nicorici, D., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-2421 · Cited by 270
Self-citationMurphy, A. J., Guyre, P. M., & Pioli, P. A. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0903463 · Cited by 257
Leivonen, S., Mäkelä, R., Östling, P., Kohonen, P. J., Haapa-Paananen, S. M., Sahlberg, K. K., Enerly, E., Aakula, A., Hellström, K., Sahlberg, N., et al. (2009) · Oncogene · doi:10.1038/onc.2009.241 · Cited by 247
Self-citationMitrunen, K., Pettersson, K. S. I., Piironen, T., Björk, T., Lilja, H. G., & Lövgren, T. N.-E. (1995) · Clinical Chemistry · doi:10.1093/clinchem/41.8.1115 · Cited by 173
Self-citationFOXO1 is a tumor suppressor in classical Hodgkin lymphoma
Xie, L., Ushmorov, A., Leithäuser, F., Guan, H., Steidl, C., Färbinger, J., Pelzer, C., Vogel, M. J., Maier, H. J., Gascoyne, R. D., et al. (2012) · Blood · doi:10.1182/blood-2011-09-381905 · Cited by 172
miR‐34c is downregulated in prostate cancer and exerts tumor suppressive functions
Hagman, Z., Larne, O., Edsjö, A., Bjartell, A. S., Ehrnström, R. A., Ulmert, D., Lilja, H. G., & Ceder, Y. (2010) · International Journal of Cancer · doi:10.1002/ijc.25269 · Cited by 165
Self-citationChapdelaine, P., Paradis, G., Tremblay, R. R., & Dubé, J. Y. (1988) · FEBS Letters · doi:10.1016/0014-5793(88)80315-6 · Cited by 138
Hagman, Z., Haflidadóttir, B. S., Ceder, J. A., Larne, O., Bjartell, A. S., Lilja, H. G., Edsjö, A., & Ceder, Y. (2013) · British Journal of Cancer · doi:10.1038/bjc.2013.131 · Cited by 128
Self-citationmicroRNA-183 is an oncogene targeting Dkk-3 and SMAD4 in prostate cancer
Ueno, K., Hirata, H., Shahryari, V., Deng, G., Tanaka, Y., Tabatabai, Z. L., Hinoda, Y., & Dahiya, R. (2013) · British Journal of Cancer · doi:10.1038/bjc.2013.125 · Cited by 122
Measurement of Prostate‐Specific Antigen and Human Glandular Kallikrein 2 in Different Body Fluids
Lövgren, J., Valtonen‐André, C., Maršál, K., LIUA, H., & Lundwall, Å. (1999) · Journal of Andrology · doi:10.1002/j.1939-4640.1999.tb02528.x · Cited by 108
Self-citationMicroRNA-650 targets ING4 to promote gastric cancer tumorigenicity
Zhang, X., Zhu, W.-Y., Zhang, J., Huo, S., Zhou, L., Gu, Z., & Zhang, M. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.04.005 · Cited by 105
Upregulation of miR-96 Enhances Cellular Proliferation of Prostate Cancer Cells through FOXO1
Haflidadóttir, B. S., Larne, O., Martin, M., Persson, M., Edsjö, A., Bjartell, A. S., & Ceder, Y. (2013) · PLoS ONE · doi:10.1371/journal.pone.0072400 · Cited by 87
Self-citationmiQ—A novel microRNA based diagnostic and prognostic tool for prostate cancer
Larne, O., Martens‐Uzunova, E. S., Hagman, Z., Edsjö, A., Lippolis, G., den Berg, M. S. V., Bjartell, A. S., Jenster, G. W., & Ceder, Y. (2012) · International Journal of Cancer · doi:10.1002/ijc.27973 · Cited by 84
Self-citationVäisänen, V., Peltola, M. T., Lilja, H. G., Nurmi, M. J., & Pettersson, K. S. I. (2006) · Analytical Chemistry · doi:10.1021/ac061201+ · Cited by 69
Self-citationBjörk, T., Piironen, T., Pettersson, K. S. I., Lövgren, T. N.-E., Stenman, U., Oesterling, J. E., Abrahamsson, P., & Lilja, H. G. (1996) · Urology · doi:10.1016/s0090-4295(96)00486-4 · Cited by 68
Self-citationOlsson, A. Y. M., Bjartell, A. S., Lilja, H. G., & Lundwall, Å. (2004) · International Journal of Cancer · doi:10.1002/ijc.20605 · Cited by 67
Self-citationMikolajczyk, S. D., Millar, L. S., Marker, K. M., Grauer, L. S., Goel, A. S., Cass, M. M. J., Kumar, A., & Saedi, M. S. (1997) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1997.00440.x · Cited by 59
Lövgren, J., Tian, S., Lundwall, Å., Karp, M. T., & Lilja, H. G. (1999) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.1999.00946.x · Cited by 38
Self-citationDiagnostic performance of microRNAs expression in prostate cancer
Yang, Q., Zheng, Y., & Zhu, D. (2014) · Tumor Biology · doi:10.1007/s13277-014-2351-9 · Cited by 11
Cited by
Beyond the biomarker role: prostate-specific antigen (PSA) in the prostate cancer microenvironment
Moradi, A., Srinivasan, S., Clements, J., & Batra, J. (2019) · Cancer and Metastasis Reviews · doi:10.1007/s10555-019-09815-3 · Cited by 114
Bioinformatic Interrogation of 5p-arm and 3p-arm Specific miRNA Expression Using TCGA Datasets
Kuo, W.-T., Su, M.-W., Lee, Y., Chen, C.-H., Wu, C.-W., Fang, W.-L., Huang, K.-H., & Lin, W.-C. (2015) · Journal of Clinical Medicine · doi:10.3390/jcm4091798 · Cited by 30
Metadata
- Authors
- Larne, O., Östling, P., Haflidadóttir, B. S., Hagman, Z., Aakula, A., Kohonen, P., Kallioniemi, O., Edsjö, A., Bjartell, A., Lilja, H., Lundwall, Å., & Ceder, Y.
- Venue
- European Urology
- Publisher
- Elsevier BV
- Published
- 2015-10
- Volume
- 68
- Issue
- 4
- Pages
- 581-588
- ISSN
- 0302-2838
- Cited by
- 38
- References
- 29
- Language
- en
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
